View Cart (0 items)

Pharmaceutical

Fatburner Dexaprine banned in UK, Netherlands

Slimming agent Dexaprine, produced by California-based company iForce Nutrition, has been banned in the Netherlands and the United Kingdom over concerns that the fatburner causes a number of life-threatening conditions.
Read More

Novartis feels the heat as China opens another bribery probe

Chinese authorities are stepping up their crusade against widespread bribery in the pharmaceutical sector with a newly launched investigation.
Read More

Chinese pharma probe spreads to two Danish drug makers

Western pharmaceutical companies are coming under increased scrutiny in China following the bribery accusations leveled last month against GlaxoSmithKline (GSK).
Read More

European biotechs back on venture capital radar

Venture capital firms are once again warming to European biotechnology players, which attracted a significant portion of the venture capital invested globally in this sector during the second quarter.
Read More

FDA sends warning letter to Indian drug maker

Mumbai-based pharmaceutical firm Wockhardt Ltd has announced that it has received a warning letter from the U.S. Food and Drug Administration (FDA) regarding the import alert on production originating from the company's Waluj facility in India.
Read More

AstraZeneca to build new HQ, research center in Cambridge, UK

AstraZeneca is investing about Ā£330 million ($515.6 million) in its new building, which will host a global R&D center.
Read More

FDA takes action against Indian pharmaceutical companies

Pharmaceutical company Hospira Inc. has been warned by the U.S. Food and Drug Administration (FDA) over lapses in the manufacturing of drugs, which were detected during an inspection of its facility in Irungattukottai, India, in October 2012.
Read More

Bayer to acquire birth control company for $1.1 billion

Conceptus' flagship product is the EssureĀ® procedure, a non-surgical permanent birth control method sold in the United States and other countries.
Read More

Sun Pharma receives tentative approval for generic version of Januvia

Indian pharmaceutical company Sun Pharma has announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the company's generic version of the successful anti-diabetes drug Januvia.
Read More

Reckitt hit by FDA approval of rival drugs

The U.S. Food and Drug Administration (FDA) has given the green light to two generic versions of Suboxone, a drug used for treating heroin addiction, manufactured by Reckitt Benckiser.
Read More